Allogeneic hematopoietic cell transplantation after infection with SARS-CoV-2 during the COVID-19 pandemic: a multicenter retrospective analysis - Top-Institutions - MDSpire

Allogeneic hematopoietic cell transplantation after infection with SARS-CoV-2 during the COVID-19 pandemic: a multicenter retrospective analysis

  • By

  • Osama Ahmad

  • Nicolaus Kröger

  • Eva Wagner-Drouet

  • David Nachbaur

  • Normann Steiner

  • Daniel Teschner

  • Sabrina Kraus

  • Gesine Bug

  • Salem Ajib

  • Johannes Schetelig

  • Wolfgang Andreas Bethge

  • Thomas Schroeder

  • Judith Schaffrath

  • Lutz Peter Müller

  • Mareike Verbeek

  • Edgar Jost

  • Hatice Soysal

  • Johanna Tischer

  • Georg-Nikolaus Franke

  • Stefan Klein

  • Udo Holtick

  • Knut Wendelin

  • Claudia Lengerke

  • Martin Bornhäuser

  • Jan Frederic Weller

  • Maximilian Christopeit

  • March 12, 2025

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Infectious Diseases

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Oncology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Infectious Diseases

  • #4

    University Hospital Heidelberg
    University Hospital Heidelberg

    Heidelberg, Baden-Württemberg

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Infectious Diseases

  • #5

    Karolinska University Hospital
    Karolinska University Hospital

    Stockholm, Stockholm County

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Infectious Diseases

Original Source(s)

Allogeneic hematopoietic cell transplantation after infection with SARS-CoV-2 during the COVID-19 pandemic: a multicenter retrospective analysis

  • by Osama Ahmad, Nicolaus Kröger, Eva Wagner-Drouet, David Nachbaur, Normann Steiner, Daniel Teschner, Sabrina Kraus, Gesine Bug, Salem Ajib, Johannes Schetelig, Wolfgang Andreas Bethge, Thomas Schroeder, Judith Schaffrath, Lutz Peter Müller, Mareike Verbeek, Edgar Jost, Hatice Soysal, Johanna Tischer, Georg-Nikolaus Franke, Stefan Klein, Udo Holtick, Knut Wendelin, Claudia Lengerke, Martin Bornhäuser, Jan Frederic Weller, Maximilian Christopeit

  • March 12, 2025

Related Content

Impact of Antiphospholipid Antibodies on COVID-19 Severity and Patient Outcomes

Improving outcomes with anti-BCMA bispecific antibodies with attention to infection

Utilizing AI-Enhanced Chest X-Rays and Hematological Indicators to Forecast Mortality and Intubation in COVID-19 Patients at a Secondary Referral Hospital in Indonesia